Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma

NCT00746330 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Mometasone furoate/formoterol fumarate (MFF)
DRUG: Formoterol fumarate 12 μg pMDI (F12M)
DRUG: Formoterol fumarate 12 μg DPI (F12D)
DRUG: Placebo to F12D
DRUG: Placebo to F12M/MFF

Sponsor

Novartis

Collaborators

[object Object]